The information highlighted (if any) are the most recent updates for this brand.
The use of high doses of human plasma prothrombin complex products has been associated with instances of myocardial infarction, disseminated intravascular coagulation, venous thrombosis and pulmonary embolism. Therefore, in case of overdose, the risk of the development of thromboembolic complications or disseminated intravascular coagulation is enhanced.